Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.

Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.

Arthritis Rheumatol. 2019 Mar;71(3):451-459. doi: 10.1002/art.40727. Epub 2019 Jan 24.

PMID:
30225949
2.

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.

Lovell DJ, Johnson AL, Huang B, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Schmidt KM, Mehta J, Wahezi DM, Ting TV, Verbsky JW, Eberhard BA, Spalding S, Chen C, Giannini EH.

Arthritis Rheumatol. 2018 Sep;70(9):1508-1518. doi: 10.1002/art.40509. Epub 2018 Jul 25.

3.

Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results.

Favier LA, Taylor J, Loiselle Rich K, Jones KB, Vora SS, Harris JG, Gottlieb BS, Robbins L, Lai JT, Lee T, Kohlheim M, Gill J, Bouslaugh L, Young A, Griffin N, Morgan EM, Modi AC.

J Rheumatol. 2018 May;45(5):690-696. doi: 10.3899/jrheum.171087. Epub 2018 Feb 1.

4.

High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.

Mor-Vaknin N, Rivas M, Legendre M, Mohan S, Yuanfan Y, Mau T, Johnson A, Huang B, Zhao L, Kimura Y, Spalding SJ, Morris PW, Gottlieb BS, Onel K, Olson JC, Edelheit BS, Shishov M, Jung LK, Cassidy EA, Prahalad S, Passo MH, Beukelman T, Mehta J, Giannini EH, Adams BS, Lovell DJ, Markovitz DM.

Arthritis Rheumatol. 2018 Apr;70(4):594-605. doi: 10.1002/art.40404. Epub 2018 Feb 22.

5.

Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.

Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, Onel KB, Schanberg LE, Rubinstein T, Gottlieb BS, Mandell DS, von Scheven E; CARRA Investigators.

J Rheumatol. 2016 Jun;43(6):1136-45. doi: 10.3899/jrheum.151228. Epub 2016 Apr 1.

PMID:
27036378
6.

Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis.

Wallace CA, Ringold S, Bohnsack J, Spalding SJ, Brunner HI, Milojevic D, Schanberg LE, Higgins GC, O'Neil KM, Gottlieb BS, Hsu J, Punaro MG, Kimura Y, Hendrickson A.

J Rheumatol. 2014 Dec;41(12):2459-65. doi: 10.3899/jrheum.140347. Epub 2014 Sep 1.

PMID:
25179849
7.

Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.

Sobel RE, Lovell DJ, Brunner HI, Weiss JE, Morris PW, Gottlieb BS, Chalom EC, Jung LK, Onel KB, Petiniot L, Goldsmith DP, Nanda K, Shishov M, Abramsky S, Young JP, Giannini EH; Pediatric Rheumatology Collaborative Study Group.

Pediatr Rheumatol Online J. 2014 Jul 16;12:29. doi: 10.1186/1546-0096-12-29. eCollection 2014.

8.

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.

Ilowite NT, Prather K, Lokhnygina Y, Schanberg LE, Elder M, Milojevic D, Verbsky JW, Spalding SJ, Kimura Y, Imundo LF, Punaro MG, Sherry DD, Tarvin SE, Zemel LS, Birmingham JD, Gottlieb BS, Miller ML, O'Neil K, Ruth NM, Wallace CA, Singer NG, Sandborg CI.

Arthritis Rheumatol. 2014 Sep;66(9):2570-9. doi: 10.1002/art.38699.

9.

Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.

Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance (CARRA).

J Rheumatol. 2014 Jun;41(6):1163-70. doi: 10.3899/jrheum.131503. Epub 2014 May 1.

PMID:
24786928
10.

Common presentations of pediatric rheumatologic diseases: a generalist's guide.

Reyhan I, Goldberg BR, Gottlieb BS.

Curr Opin Pediatr. 2013 Jun;25(3):388-96. doi: 10.1097/MOP.0b013e328360c2fd. Review.

PMID:
23652686
11.

Juvenile idiopathic arthritis.

Espinosa M, Gottlieb BS.

Pediatr Rev. 2012 Jul;33(7):303-13. doi: 10.1542/pir.33-7-303. Review.

PMID:
22753788
12.

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic D, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Hamilton S, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance.

Arthritis Rheum. 2012 Jun;64(6):2012-21. doi: 10.1002/art.34343. Epub 2011 Dec 19.

13.

Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis.

Lovell DJ, Passo MH, Beukelman T, Bowyer SL, Gottlieb BS, Henrickson M, Ilowite NT, Kimura Y, DeWitt EM, Segerman J, Stein LD, Taylor J, Vehe RK, Giannini EH.

Arthritis Care Res (Hoboken). 2011 Jan;63(1):10-6. doi: 10.1002/acr.20348.

14.

Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis.

Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, Fall N, Sowders DP, Hinze CH, Aronow BJ, Luyrink LK, Srivastava S, Ilowite NT, Gottlieb BS, Olson JC, Sherry DD, Glass DN, Colbert RA.

Arthritis Rheum. 2009 Jul;60(7):2102-12. doi: 10.1002/art.24601.

15.

Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.

Griffin TA, Barnes MG, Ilowite NT, Olson JC, Sherry DD, Gottlieb BS, Aronow BJ, Pavlidis P, Hinze CH, Thornton S, Thompson SD, Grom AA, Colbert RA, Glass DN.

Arthritis Rheum. 2009 Jul;60(7):2113-23. doi: 10.1002/art.24534.

16.

Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.

Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite NT, Gottlieb BS, Griffin T, Sherry DD, Thompson S, Glass DN, Colbert RA, Grom AA.

Arthritis Rheum. 2007 Nov;56(11):3793-804.

17.

Flares in pediatric systemic lupus erythematosus.

Weiss JE, Sison CP, Ilowite NT, Gottlieb BS, Eberhard BA.

J Rheumatol. 2007 Jun;34(6):1341-4. Epub 2007 May 1.

PMID:
17477466
18.

Systemic lupus erythematosus in children and adolescents.

Gottlieb BS, Ilowite NT.

Pediatr Rev. 2006 Sep;27(9):323-30. Review. No abstract available.

PMID:
16950937
19.

A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis.

Jones OY, Spencer CH, Bowyer SL, Dent PB, Gottlieb BS, Rabinovich CE.

Pediatrics. 2006 May;117(5):e840-4.

PMID:
16651289
20.

Development and evaluation of a cognitive-behavioral intervention for juvenile fibromyalgia.

Degotardi PJ, Klass ES, Rosenberg BS, Fox DG, Gallelli KA, Gottlieb BS.

J Pediatr Psychol. 2006 Aug;31(7):714-23. Epub 2005 Aug 24.

PMID:
16120766
21.
22.

Infliximab as a novel therapy for refractory Kawasaki disease.

Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.

J Rheumatol. 2004 Apr;31(4):808-10.

PMID:
15088313
23.

Bone marrow transplants do not help in breast cancer.

Gottlieb bS.

BMJ. 1999 Apr 24;318(7191):1093. No abstract available.

24.

Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis.

Gottlieb BS, Keenan GF, Lu T, Ilowite NT.

Pediatrics. 1997 Dec;100(6):994-7.

PMID:
9374571
25.

Methotrexate treatment of Wegener granulomatosis in children.

Gottlieb BS, Miller LC, Ilowite NT.

J Pediatr. 1996 Oct;129(4):604-7.

PMID:
8859270
26.

Alleviation of autotransfusion-induced haematological damage by corticosteroids.

Stillman RM, Gottlieb BS, Sawyer PN.

Br J Surg. 1980 Feb;67(2):99-100.

PMID:
7362957
27.

A comparison of response exaggeration techniques.

Gottlieb BS, McNamara JR.

J Clin Psychol. 1979 Oct;35(4):776-8.

PMID:
512005

Supplemental Content

Loading ...
Support Center